Cargando…
Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies
Randomized controlled trials (RCTs) are the gold‐standard for benefit–risk assessments during drug approval processes. Real‐word data (RWD) and the resulting real‐world evidence (RWE) are becoming increasingly important for assessing the effectiveness of drug products after marketing authorization s...
Autores principales: | Vogelberg, Christian, Klimek, Ludger, Brüggenjürgen, Bernd, Jutel, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087412/ https://www.ncbi.nlm.nih.gov/pubmed/36074052 http://dx.doi.org/10.1111/all.15506 |
Ejemplares similares
-
Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
por: Vogelberg, Christian, et al.
Publicado: (2020) -
Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany
por: Brehler, Randolf, et al.
Publicado: (2016) -
Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014) -
Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
por: Pfaar, Oliver, et al.
Publicado: (2023) -
Allergen Immunotherapy: Past, Present, and Future
por: Jutel, Marek, et al.
Publicado: (2016)